Revealing Lung Cancer Insights
Plasma proteome profiling at scale for biomarker discovery
Lung cancer is the leading cause of cancer-related deaths worldwide, yet studying the disease has remained challenging due to complex etiological factors.
In this webinar, you’ll hear how one of the largest multiomics observational studies to date has revealed lung cancer biomarkers from the blood plasma proteome. Our expert speakers will discuss how the research sheds new light on early-stage lung cancer diagnostics and clinical outcomes and showcase how multiomics approaches are key for characterizing complex diseases.
They’ll also highlight the extensive clinical applications of multiomics platforms in ongoing population studies for biomarker discovery.
This webinar is best for:
- Proteomics and genomics research professionals.
- Scientists focused on the study of cancer biomarkers and the plasma proteome.
- General scientific community.
Things you’ll learn about:
- Hear how analysis of the plasma proteome identified peptide and RNA transcript biomarkers.
- Gain insights into the accuracy of non-invasive multiomics approaches to lung cancer diagnostics.
- Discover a multiomics platform that facilitates population-wide biomarker discovery studies.
Featured Speakers
Bruce Wilcox, Ph.D. Chief Technology Officer, PrognomiQ
Shao-Yung (Eric) Chen, Ph.D. Marketing Application Scientist, Seer
Watch Webinar On-Demand
Fill out the form to watch the webinar.